Contraceptive options for individuals and couples range widely, from barrier methods to short- and long-acting reversible contraception to permanent sterilization. Around the world, sterilization is the chosen option for more than 220 million couples desiring contraception. Data from the National Survey of Family Growth show that from 2006 to 2010, sterilization was the most common method of contraception used in the United States, utilized by 47.3% of married couples. Tubal ligation accounted for 30.2% and vasectomy for 17.1%. For those who have completed childbearing, sterilization using tubal ligation is a safe and effective contraceptive option. Additionally, tubal ligation may have non-contraceptive benefits, such as improved menstrual bleeding patterns and decreased risks of ovarian cancer. Most tubal ligations are performed in an ambulatory setting on an outpatient basis unless performed after cesarean section or in the period immediately postpartum. As with any procedure, the patient must understand the risks, benefits, indications, and alternatives.
The Fallopian tube, also known by the names uterine tube or oviduct, is named after the Italian anatomist Gabriel Fallopius. It is a J-shaped structure that is an essential component of the female reproductive tract. Each tube is approximately 10 to 12 cm long. The uterine tubes are paired, located at the superior aspect of the uterine cavity bilaterally. Each tube exits the uterus at the uterine cornua and appears between the round and utero-ovarian ligaments at the upper margins of the broad ligament bilaterally. The peritoneum of the broad ligament immediately inferior to the Fallopian tube is called the mesosalpinx.
Embryologically, the Fallopian tubes derive from the coelomic epithelium via the paramesonephric ducts. Between week five and week six after fertilization, Muller’s groove arises on each side laterally to the mesonephric duct. Muller’s groove originates from the coelomic epithelium, and the edges of this groove form the paramesonephric or Mullerian ducts. These paramesonephric ducts, in turn, fuse in the eighth week to form the uterus, Fallopian tubes, cervix, and upper two-thirds of the vagina.
The primary function of the Fallopian tube is to transport sperm toward the egg/ovum and then allow the fertilized egg to travel back to the uterus for implantation. Thus, occlusion or removal of the Fallopian tube acts to prevent fertilization and subsequent pregnancy. At least 3 cm of the isthmus of the tube must undergo complete coagulation if electrocoagulation is being utilized to perform a tubal ligation.
The primary indication for tubal ligation is the desire for permanent sterilization. Those who have completed childbearing and desire a non-reversible contraceptive option are candidates for tubal ligation. Removal of the Fallopian tubes, or salpingectomy, has been advocated as a method for the prevention of ovarian cancer. The surgeon can perform salpingectomy opportunistically as a method of tubal ligation at the time of hysterectomy. Currently, bilateral salpingectomy alone is not the recommendation for risk reduction in patients with a high risk of ovarian cancer, such as BRCA mutation carriers.
The main contraindication to tubal ligation is a patient’s desire for future childbearing. While tubal anastomosis or in-vitro fertilization (IVF) is an option for some patients, success cannot be guaranteed, and cost can be a significant barrier for many. In one review of tubal anastomosis, pooled pregnancy rates for the procedure were 42 to 69% but varied by the method used.
Various methods of tubal ligation carry individual surgical risks. Some patients may not qualify as good surgical candidates for abdominal or laparoscopic surgery (e.g., obesity, adhesive disease, medical comorbidities). Anesthesia carries risk. Some patients, anatomically, may not be candidates for tubal occlusion techniques with clips or rings if their Fallopian tubes are abnormal.
The consent process for tubal ligation must be careful and complete. In counseling patients regarding tubal ligation, it should be made clear that the procedure is permanent and not intended to be reversible. Alternatives, such as long-acting reversible contraceptives or vasectomy, should be discussed. Patients must also understand the details of the procedure itself and any associated risks, as well as the risks and benefits of anesthesia. Counseling should include a discussion regarding the risks of failure and ectopic pregnancy. As tubal ligation does not protect against sexually transmitted infections, patients who are at risk should use barrier methods even after sterilization. Lastly, providers and patients all need to be aware of any local laws or regulations regarding sterilization.
Even if counseling is adequate, there remains a risk of regret after tubal ligation. The CREST study found a cumulative probability of regret of 12.7% over 14 years. Regret can be challenging to quantify, and in some studies, a request for information regarding a reversal procedure has served as a marker of regret. However, clinicians should not automatically deny the procedure to patients who have risk factors for regret.
For patients planning postpartum sterilization, patients and providers should consider postponing the procedure if there are intrapartum or postpartum neonatal or maternal complications.
Ethically, tubal ligation in specific populations can be challenging. For example, ensuring adequate informed consent and a lack of coercion in the incarcerated population can be difficult. Between 2006 and 2010, over 140 women in California prisons underwent publicly funded tubal ligations. Despite all of these having signed consent forms, analysis by researchers after the fact showed that many of the women felt significant pressure from both prison and hospital physicians and that many of the procedures were undesired . On the other hand, some incarcerated women may genuinely desire sterilization. Overall, the recommendation is that incarcerated women should only (rarely) undergo sterilization after excellent documentation (preferably pre-incarceration) and access to long-acting reversible methods are made available.
Patients who may be uncertain regarding permanent sterilization but who desire effective contraception should receive counsel regarding other highly-effective contraceptive options. For example, the estimated failure rate of tubal ligation is 0.5 per 100 women in the first year. Comparatively, the levonorgestrel intrauterine device is 0.2 per 100, the copper IUD is 0.8 per 100, and the contraceptive implant is 0.05 per 100 women in the first year. Therefore, the availability of contraceptive options with similar efficacy to tubal ligation, but that are also reversible, is a crucial part of patient informed consent. If a patient is in a relationship with a male partner and the couple desires sterilization, vasectomy is an alternative to tubal ligation, with a failure rate of 0.15 per 100 women in the first year.
Ultimately, the choice to have a tubal ligation is an individual one.
The equipment needed for tubal ligation varies based on the technique and approach. To perform a tubal ligation, the surgeon must first visualize the Fallopian tube. Following visualization, the patency between ovary/ovum and uterus must be interrupted.
During a cesarean section, the visualization of the Fallopian tube is often simple after the uterus becomes exteriorized. The surgeon can grasp the tube with a Babcock clamp and the chosen technique utilized. If the uterus is not exteriorized, or if it cannot be, visualization of the tube can be more difficult depending on the amount of adhesive disease present. Various retractors, such as a Richardson retractor, may be utilized to aid in visualizing the tube. The Bovie cautery used during the cesarean can also be used during the tubal ligation.
For a postpartum or postabortion procedure, access to the Fallopian tube is achieved using a mini-laparotomy incision. A scalpel, several small retractors (such as a Senn or Army-Navy retractor), and surgical scissors (such as Metzenbaum or Mayo scissors) will suffice. A suction tip, such as a Yankauer, may also be utilized. A clamp such as a Babcock is again used to grasp the tube once it is in the surgical incision, and the chosen technique for tubal ligation can take place.
Surgeons often perform interval procedures laparoscopically. Therefore, standard laparoscopic equipment is necessary, including the laparoscope, CO2 gas and tubing, light, video equipment, trocars, and graspers. Equipment for the chosen technique of laparoscopic entry is required, per surgeon preference. Once abdominal entry is achieved and the Fallopian tube visualized laparoscopically, the chosen method for tubal ligation can commence.
If utilizing electrocautery, as in some laparoscopic tubal ligations, a bipolar energy source and instrument (Kleppinger) are necessary. Laparoscopic bilateral salpingectomy can also be performed, for example, using a bipolar combination sealing/cutting instrument. Various clips and bands may also help occlude the Fallopian tubes during laparoscopy. Clips or bands are also options during postpartum/postabortion sterilizations or cesarean sections. Open techniques utilizing suture are common. With the increase in salpingectomy, some physicians are choosing to use laparoscopic bipolar sealing/cutting instruments at the time of postpartum or cesarean tubal ligations.
Closure of the skin incision(s) can be achieved using sutures and/or skin glue.
Hysteroscopic sterilization techniques have been described and used, though they are no longer widely utilized in the United States. If the surgeon chooses this technique, then hysteroscopic equipment (hysteroscope, distension medium, light, video equipment, etc.) is needed, along with vaginal instruments (speculum or retractors, tenaculum, dilators, etc.). Whatever method is being utilized to occlude the tubes is also necessary.
The an interprofessional team includes:
The most critical aspect of preparing for tubal ligation is ensuring adequate patient counseling and informed consent. Appropriate documentation and consent forms should be in place before the procedure. Laws and restrictions regarding timing and the consent process require careful adherence. The technique and approach most appropriate for the individual patient must also be determined, which will allow adequate counseling with regards to any surgical risks, risks of failure, risks of anesthesia, recovery, and follow-up unique to each technique or approach.
The timing of tubal ligation can be :
Appropriate skin preparation preoperatively should be performed. Prophylactic antibiotics are not recommended prior to laparoscopic tubal ligations. Antibiotics are also not routinely administered before mini-laparotomy. The patient should have an empty stomach appropriate for the surgical approach chosen.
This is the most common technique for interval tubal ligations. It allows for inspection of the abdomen and pelvis, is effective immediately, and allows a relatively rapid return to activity. Anesthesia is typically general; however, this can take place with local anesthetic and sedation. Laparoscopic tubal ligation is possible via three methods :
In the United States, there are currently no hysteroscopic sterilization devices on the market. Hysteroscopic sterilization cannot be done postpartum or postabortion. It offers a relatively non-invasive method for tubal occlusion that could be beneficial to patients who are weak surgical candidates, and it has the benefit of being able to be performed in the office setting. The hysteroscopic technique involves introducing medicine into the Fallopian tubes via the tubal ostia, which subsequently block or scar the tubes. Some past hysteroscopic techniques required follow-up imaging to ensure occlusion. Either sedation or general anesthesia are options if this procedure occurs in the operating room. In the office setting, a paracervical block or light sedation are options if safely available.
This technique is generally used for postpartum procedures, though it may merit consideration for patients for whom laparoscopy carries such a high risk that laparotomy is safer. It is also suitable for low-resource settings, because it utilizes basic (and usually reusable) equipment, unlike laparoscopy. A 2 to 3 cm incision is made relative to the fundus (infra-umbilical postpartum or suprapubic postabortion/interval), though a larger incision may be necessary for obese patients. During a cesarean postpartum tubal ligation, the abdomen is already open. The patient's existing regional anesthetic is sufficient for procedures done during a cesarean. After a vaginal delivery, the patient's epidural catheter may remain in place, or a spinal anesthetic can be placed if the patient did not have an epidural or if the epidural catheter required removal.
Tubal segments require a pathology consultation to confirm transection. A common structure ligated accidentally is the round ligament. Identification of the fimbriated end of the Fallopian tube before excision can help confirm the correct structure. Unless performing a complete salpingectomy, care is necessary to excise a sufficient section of the Fallopian tube. All cut edges require inspection for hemostasis.
Laparoscopic tubal ligation is overall safe and effective. Mortality rates in the United States are estimated at 1 to 2 per 100000 procedures, with most deaths attributable to hypoventilation and cardiopulmonary arrest while administering general anesthesia. Several studies have shown no deaths at all. Major laparoscopic complications include unplanned major surgery, transfusion, damage to surrounding structures, fever, infection, bleeding, transfusion, and readmission. These reports show approximately 0.9 to 1.6 per 100 procedures. The reported risk of conversion to open laparotomy is 0.9 per 100 cases. The risks of complications increase with the use of general anesthesia, previous pelvic or abdominal surgery, obesity, and diabetes.
Complications following mini-laparotomy are also very low. In one Swiss study, the overall rate of major morbidity after postpartum tubal ligation was 0.39%. This statistic included cases of blood loss greater than 500cc, febrile morbidity, pulmonary embolism, and stomach injury. The rate of minor morbidity was 0.8%, including urinary tract infections, wound dehiscence, abdominal wall hematomas, uterine injury, and ileus.
Since the original CREST study was published, additional data regarding method efficacy have emerged, and follow-up analyses have taken place on the CREST data. Bipolar coagulation has specifically received attention. During the follow-up period, as techniques evolved, the failure rates fell significantly.
Care should be taken to identify luteal phase pregnancies before performing interval tubal ligations. A pregnancy test is necessary, but also a careful history should be taken to identify patients at risk of being pregnant despite a negative pregnancy test. On average, women ovulate on day 14 of their cycle, where day 1 of the cycle is day 1 of the last menstrual period. The fertile period extends from several days before ovulation to shortly after, and many urine pregnancy tests do not have the sensitivity to detect very early pregnancy. Patients who have had unprotected intercourse within the last week could be at risk of luteal phase pregnancy. Patients at risk should be counseled preoperatively regarding the risks of surgery and anesthesia during early pregnancy, and the risks merit strong consideration against the benefits of proceeding with the procedure.
Post-tubal ligation syndrome is a potential complication that is well-documented in the lay media. Its actual existence, however, controversial. Symptoms may include dyspareunia, low back pain, premenstrual tension syndrome, menstrual abnormalities (missed periods, heavy menstrual bleeding), or menopausal symptoms. The etiology of post-tubal ligation syndrome may be related to adnexal vascular disruption. Treatment may be symptomatic if patient bother is mild. However, some patients may require/request surgical management, such as reversal of the tubal ligation.
Female sterilization is the most common method of contraception used worldwide. It can be done immediately after delivery or between pregnancies, and the number of techniques available is many. It is crucial to understand the complexities surrounding tubal ligation, including the various surgical risks/benefits/alternatives, alternative contraceptive options, and the challenging ethics involved. An adequate understanding of all these is necessary to counsel patients adequately and obtain valid informed consent.
Approximately half of all pregnancies in the United States are unintended. Tubal ligation offers patients a safe and effective contraceptive option that has a low failure rate, has no risk of user-related failure, and does not require replacement. Barriers do exist concerning access to postpartum sterilization. Unfortunately, only 50% of patients who request postpartum tubal ligation ultimately undergo the procedure. A patient must be 21 years old to be eligible for Medicaid coverage of a sterilization procedure, and consent documents must be signed at least 30 days before the procedure. Operating rooms or anesthesia may not be available, or the institution may be religiously affiliated. Physicians, nurses, anesthesiologists, office staff, and other patient advocates can work together to ensure proper patient education and access to services such as postpartum tubal ligation. Hospital systems and medical providers can develop policies and procedures to ensure consent forms are obtained in the antenatal period and are available at the time of delivery. Providers, including nurses, can emphasize that postpartum tubal ligations are urgent and advocate for these procedures to be scheduled and done. Women receiving care at religiously-affiliated institutions should still be counseled regarding all their options and be offered referrals to other institutions if they desire. [Level V]
Ethically, providers who counsel patients regarding tubal ligation or who participate in these patients’ care may be better able to ensure patient satisfaction and outcomes if they also understand the CREST study and potential pitfalls such as regret and failure. [Level II]
One study looking at written informed consent for tubal ligation found wide variations in the complications discussed, both among providers with the same level of training and between levels of training. This data leaves providers at risk legally. The authors concluded by recommending standardized patient education that can aid in obtaining consistently valid informed consent. This standardized education could be helpful for all members of each patient's healthcare team. [Level V]
|||ACOG Practice Bulletin No. 208: Benefits and Risks of Sterilization. Obstetrics and gynecology. 2019 Mar; [PubMed PMID: 30640233]|
|||Foti PV,Ognibene N,Spadola S,Caltabiano R,Farina R,Palmucci S,Milone P,Ettorre GC, Non-neoplastic diseases of the fallopian tube: MR imaging with emphasis on diffusion-weighted imaging. Insights into imaging. 2016 Jun; [PubMed PMID: 26992404]|
|||Eddy CA, Tubal physiology and microsurgery. The Australian [PubMed PMID: 7036982]|
|||ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention. Obstetrics and gynecology. 2019 Apr; [PubMed PMID: 30913199]|
|||Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome. Obstetrics and gynecology. 2017 Sep; [PubMed PMID: 28832484]|
|||van Seeters JAH,Chua SJ,Mol BWJ,Koks CAM, Tubal anastomosis after previous sterilization: a systematic review. Human reproduction update. 2017 May 1; [PubMed PMID: 28333337]|
|||Hillis SD,Marchbanks PA,Tylor LR,Peterson HB, Poststerilization regret: findings from the United States Collaborative Review of Sterilization. Obstetrics and gynecology. 1999 Jun; [PubMed PMID: 10362150]|
|||Committee Opinion No 695 Summary: Sterilization of Women: Ethical Issues and Considerations. Obstetrics and gynecology. 2017 Apr; [PubMed PMID: 28333815]|
|||Steiner MJ,Trussell J,Mehta N,Condon S,Subramaniam S,Bourne D, Communicating contraceptive effectiveness: A randomized controlled trial to inform a World Health Organization family planning handbook. American journal of obstetrics and gynecology. 2006 Jul; [PubMed PMID: 16626610]|
|||Huber AW,Mueller MD,Ghezzi F,Cromi A,Dreher E,Raio L, Tubal sterilization: complications of laparoscopy and minilaparotomy. European journal of obstetrics, gynecology, and reproductive biology. 2007 Sep; [PubMed PMID: 16872736]|
|||Peterson HB,Xia Z,Hughes JM,Wilcox LS,Tylor LR,Trussell J, The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. American journal of obstetrics and gynecology. 1996 Apr; [PubMed PMID: 8623843]|
|||Peterson HB,Xia Z,Wilcox LS,Tylor LR,Trussell J, Pregnancy after tubal sterilization with bipolar electrocoagulation. U.S. Collaborative Review of Sterilization Working Group. Obstetrics and gynecology. 1999 Aug; [PubMed PMID: 10432120]|
|||Satoh K,Osada H, [Post-tubal ligation syndrome]. Ryoikibetsu shokogun shirizu. 1993; [PubMed PMID: 7757737]|
|||Committee opinion no. 530: access to postpartum sterilization. Obstetrics and gynecology. 2012 Jul; [PubMed PMID: 22914423]|
|||Bharathan R,Rawesh R,Ahmed H, Written consent for laparoscopic tubal occlusion and medico-legal implications. The journal of family planning and reproductive health care. 2009 Jul; [PubMed PMID: 19622209]|